Survival study of leukoplakia malignant transformation in a region of northern Spain

  1. Pilar Gándara Vila 1
  2. Mario Pérez-Sayáns 2
  3. José Manuel Suárez Peñaranda 3
  4. M. Mercedes Gallas Torreira 1
  5. José Manuel Somoza Martín 1
  6. Dolores Reboiras López 1
  7. Andrés Blanco Carrión 1
  8. Abel García García 4
  1. 1 PhD, DDS. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry, Santiago de Compostela, Spain
  2. 2 PhD, DDS. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry. Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain
  3. 3 MD, PhD. Department of Pathology and Forensic Sciences. University Hospital and School of Medicine of Santiago de Compostela
  4. 4 MD, PhD. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry. Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain
Revista:
Medicina oral, patología oral y cirugía bucal. Ed. inglesa

ISSN: 1698-6946

Ano de publicación: 2018

Volume: 23

Número: 4

Páxinas: 6

Tipo: Artigo

DOI: 10.4317/MEDORAL.22326 DIALNET GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: Medicina oral, patología oral y cirugía bucal. Ed. inglesa

Objetivos de desarrollo sostenible

Resumo

Oral leukoplakia is the most common potentially malignant disorder (PMD) of the oral cavity. The objectives of this study are to determine the clinicopathologic features in a group of patients with oral leukoplakia of Northern Spain (Galicia), determining the factors associated to clinical risk and analyzing the malignant transformation of these patients. We included 85 patients. We recorded sex and age, habits like alcohol and tobacco, size, clinical appearance, site, number of lesions, and presence or absence of dysplasia. We assess the association between risk factors and transformation and developed a logistic regression analysis. Finally we used the Kaplan-Meier and log-rank test for the survival analysis. 7 patients (8.2%) had malignant transformation. The mean follow-up of the patients was 4.13 years versus 5.58 years of those who developed carcinoma. Only location and initial dysplasia have a statistically significant relationship with malignant transformation, but when applied the long rank test only the presence of dysplasia remains statistically significant(P<0,026). Oral Cancer Free Survival was 81.9% (0.150) at 11 years for the group without dysplasia. We found that the presence of dysplasia is the only risk factor that is statistically related to the development of a carcinoma.

Referencias bibliográficas

  • Petti, . (2003). Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 39. 770
  • Warnakulasuriya, KA,Ralhan, . (2007). Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco--a review. J Oral Pathol Med. 36. 63-77
  • Lee, JJ,Hong, WK,Hittelman, WN,Mao, L,Lotan, R,Shin, D. (2000). Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 6. 1702
  • Warnakulasuriya, S,Ariyawardana, . (2015). Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 45. 155
  • Silverman, S,Bhargava, K,Smith, LW,Malaowalla, A. (1976). Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India. Cancer. 38. 1790
  • Napier, SS,Cowan, CG,Gregg, TA,Stevenson, M,Lamey, PJ,Toner, P. (2003). Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis. 9. 129
  • Silverman, S Jr,Gorsky, . (1997). Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 84. 154
  • Scully, . (2014). Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia. Oral Dis. 20. 1-5
  • Bouquot, JE,Speight, PM,Farthing, P. (2006). Epithelial dysplasia of the oral mucosa—Diagnostic problems and prognostic features. Current Diagnostic Pathology. 12. 11-21
  • Amagasa, T,Yamashiro, M,Ishikawa, . (2006). Oral Leukoplakia Related to Malignant Transformation. Oral Science International. 3. 45-55
  • Schepman, KP,van der Meij, EH,Smeele, LE,van der Waal, . (1998). Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 34. 270
  • Lind, P. (1987). Malignant transformation in oral leukoplakia. Scand J Dent Res. 95. 449
  • Silverman, S Jr,Gorsky, M,Lozada, . (1984). Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 53. 563
  • van der Waal, I,Schepman, KP,van der Meij, EH,Smeele, L. (1997). Oral leukoplakia: a clinicopathological review. Oral Oncol. 33. 291-301
  • Holmstrup, P,Vedtofte, P,Reibel, J,Stoltze, . (2006). Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 42. 461-474
  • Ho, MW,Risk, JM,Woolgar, JA,Field, EA,Field, JK,Steele, J. (2012). The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol. 48. 969
  • Brouns, E,Baart, J,Karagozoglu, K,Aartman, I,Bloemena, E,van der Waal, . (2014). Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 20. 19-24
  • Liu, W,Shi, LJ,Wu, L,Feng, JQ,Yang, X,Li, . (2012). Oral cancer development in patients with leukoplakia--clinicopathological factors affecting outcome. PLoS One. 7. 34773
  • Lee, JJ,Hung, HC,Cheng, SJ,Chen, YJ,Chiang, CP,Liu, B. (2006). Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 101. 472
  • Liu, W,Bao, ZX,Shi, LJ,Tang, GY,Zhou, Z. (2011). Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases. Histopathology. 59. 733
  • Xia, RH,Song, XM,Wang, XJ,Li, J,Mao, . (2013). The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia. PLoS One. 8. 66794
  • Schaaij-Visser, TB,Bremmer, JF,Braakhuis, BJ,Heck, AJ,Slijper, M,van der Waal, . (2010). Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Oral Oncol. 46. 123
  • Liu, W,Wang, YF,Zhou, HW,Shi, P,Zhou, ZT,Tang, G. (2010). Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 10. 685
  • Warnakulasuriya, S,Johnson, NW,van der Waal, . (2007). Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 36. 575
  • (2017). In vitro comparison between Fluorinex® method and traditional topical fluoridation. Geneva.
  • van der Waal, I,Axell, . (2002). Oral leukoplakia: a proposal for uniform reporting. Oral Oncol. 38. 521
  • Jaber, M. (2010). Oral epithelial dysplasia in non-users of tobacco and alcohol: an analysis of clinicopathologic characteristics and treatment outcome. J Oral Sci. 52. 13-21
  • Gale, N,Pilch, BZ,Sidransky, D,El Naggar, A,Westra, W,Califano, . (2005). Epithelial precursor lesions. In: Barnes L, Eveson JW, Reichart P, Sidransky D (ed). World health organization classification of tumours. Pathology and genetics. IARC Press. Lyon.
  • Brouns, ER,Baart, JA,Bloemena, E,Karagozoglu, H,van der Waal, . (2013). The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal. 18. 19-26
  • van der Waal, I,Schepman, KP,van der Meij, E. (2000). A modified classification and staging system for oral leukoplakia. Oral Oncol. 36. 264
  • Schepman, KP,van der Waal, . (1995). A proposal for a classification and staging system for oral leukoplakia: a preliminary study. Eur J Cancer B Oral Oncol. 31. 396
  • Chandu, A,Smith, A. (2005). The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg. 34. 396-400
  • Banoczy, . (1997). Follow-up studies in oral leukoplakia. J Maxillofac Surg. 5. 69-75
  • Lumerman, H,Freedman, P,Kerpel, . (1995). Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 79. 321
  • Slaughter, DP,Southwick, HW,Smejkal, . (1953). Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 6. 963
  • Thomson, P. (2002). Field change and oral cancer: new evidence for widespread carcinogenesis?. Int J Oral Maxillofac Surg. 31. 262
  • Chandran, R,Meer, S,Feller, . (2013). Oral leukoplakia in a South African sample: a clinicopathological study. Oral Dis. 19. 592
  • Saito, T,Sugiura, C,Hirai, A,Notani, K,Totsuka, Y,Shindoh, . (2001). Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg. 30. 49-53
  • Mashberg, A,Meyers, . (1076). Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas: a continuing prospective study of oral cancer. II. Cancer. 37. 2149
  • Castagnola, P,Malacarne, D,Scaruffi, P,Maffei, M,Donadini, A,Di Nallo, . (2011). Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue. BMC Cancer. 11. 445
  • Zhang, L,Cheung, KJ Jr,Lam, WL,Cheng, X,Poh, . (2001). Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer. 91. 2148